Back to Research

Organization profile

NXI Therapeutics

[Confidence Level: High] NXI Therapeutics is a Basel-based biotechnology organization developing selective immunosuppressants that target the Coronin 1 signaling pathway to treat autoimmune diseases and organ transplant rejection.16

Basel, SwitzerlandFounded 2021

Overview

[Confidence Level: High] NXI Therapeutics is a Basel-based biotechnology organization developing selective immunosuppressants that target the Coronin 1 signaling pathway to treat autoimmune diseases and organ transplant rejection.16

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.